Myriad Genetics (MYGN) Stock: Buy, Sell, or Hold?
MYGN - Myriad Genetics Inc
$5.82
0.06 (1.04%)
▲
5d:
+46.23%
30d:
+40.58%
90d:
+6.79%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 04, 2026
10d
Get Alerted When MYGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: MYGN is 18.8% above its trading range ($4.90). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: MYGN is 18.8% above its trading range ($4.90). Market expects 0% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: MYGN is currently trading at $5.82, which is considered extended relative to its 30-day fair value range of $3.80 to $4.90. From a valuation perspective, the stock is trading at a discount (Forward PE: -9.9) compared to its historical average (50.8). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MYGN is in a downtrend. The price is approaching resistance at $5.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MYGN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $4.49. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MYGN is in a downtrend. The price is approaching resistance at $5.95. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MYGN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $4.49. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.80 -
$4.90
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
14.3%
Protect Your Profits
MYGN is technically overbought (RSI 74). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+18.8% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 22.9% above Wall St target ($4.49)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.80 -
$4.90
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.95
Resistance Level
$5.95
Current Trend
Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.89
Wall Street Target
$4.49
(-22.9%)
Revenue Growth (YoY)
-10.5%
Profit Margin
-14.0%
PE vs Historical
-9.9 vs 50.8
CHEAP
Share & Embed Analysis
Last updated: October 23, 2026 11:10 PM ET
Data refreshes hourly during market hours. Next update: 12:10 AM
Data refreshes hourly during market hours. Next update: 12:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MYGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$202 | 67 BUY |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
28 analysts |
$691 | 48 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$404 | 54 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$244 | 45 HOLD |
Advanced MYGN Option Strategies
Professional options setups generated by AI based on today's MYGN price and gamma walls.
